Trade Assist May Not Be Available For All Jump Trades (See Trade Plan

Ticker delayed 20 minutes



Avg Daily Volume: 7,339,249    Market Cap: 2.04B
Sector: Services    Short Interest: 71.91


     THIS QTR:   EPS:               .02/share     REV:  2,850/M
     LAST QTR:  EPS:                .27/share      ACTUAL: .34/share  (BEAT)
     NEXT QTR:  EPS:               1.47/share     REV:  3,150/M
     FULL YR:     EPS:               1.92/share     REV: 11,320/M

*These are the base metrics we will be watching against the actual release numbers


PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 6.48, -9.46, -12.6


Links To Latest News and Headlines

Bed Bath & Beyond Inc. (Nasdaq: BBBY) has named Elizabeth Meltzer as Senior Vice President (SVP), General Merchandising Manager for its Bed, Bath and Home Décor categories, effective November 2, 2020. Ms. Meltzer will join the Company’s merchandising leadership team, reporting to Joe Hartsig, Executive Vice President & Chief Merchandising Officer, and President of Harmon Health and Beauty Stores.

Does Bed Bath & Beyond (BBBY) have what it takes to be a top stock pick for momentum investors? Let’s find out.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Bed Bath & Beyond Inc. (Nasdaq: BBBY) has appointed Mary-Farrell Tarbox and Ann-Marie Clendenin as Regional Vice Presidents (RVP) for the Central and East regions respectively, effective October 26, 2020. Both Ms. Tarbox and Ms. Clendenin will report directly to Executive Vice President and Chief Stores Officer, Gregg Melnick, to round out Bed Bath & Beyond’s store leadership team. Ms. Tarbox will be responsible for over 350 of Bed Bath & Beyond’s retail stores across 22 states, while Ms. Clendenin will oversee another approximately 200 stores across 12 states.

The market response to Bed Bath & Beyond (NASDAQ: BBBY) fundamentally restructuring itself by shedding noncore assets and focusing on its digital future has caused its stock price to double. Shares in the home goods retailer over the last 30 days have risen from about $12 to over $24, and now an analyst thinks they can double again. Baird analyst Peter Benedict told investors in a research note that despite Bed Bath & Beyond’s meteoric rise, the bullish case remains weighed down by doubt.

StockJumpers analysis and trade plans are uploaded generally 1 HOUR (3PM EST) for most events.

“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up  Looking forward to having you on-board ASAP”

There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory. 

NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.